Drug Discovery 2022: driving the next life science revolution

Sengenics

Sengenics
Where: E11
Sengenics is proud to be a sponsor of this year's ELRIG Drug Discovery!

Sengenics is a precision medicine company working to improve patient outcomes through physiologically relevant, data-guided decision-making. Our solutions enable the discovery and validation of autoantibody biomarker signatures for patient stratification, drug response prediction, and development of companion diagnostics.
Tel: -
Address: 44 Manning Rd
Billerica, MA
Website: https://sengenics.com/
Email: enquiries@sengenics.com

Staff Attending

Büsgen
Dr Tanja Büsgen
Director of Sales - Central Europe
Sengenics
United States
View Profile  
Churchman
Mr Adrian Churchman
Head of EU &UK
Sengenics
View Profile  

Find out more...

To view the virtial stand - please login first Brochure Sengenics Autoantibody Biomarker Discovery Brochure

Brochure White Paper: Autoantibody Discovery using a Novel Microarray of Functional Proteins

Brochure White Paper: Fully Functional Protein Microarray for Predictive Toxicology Studies

Brochure White Paper: Assessing RA-patient Autoantibody Response to Citrullinated Immunome Proteins

LinkedIn URL

Twitter

Hosted By

ELRIG

The European Laboratory Research & Innovation Group Our Vision : To provide outstanding, leading edge knowledge to the life sciences community on an open access basis

Get the App

Get this event information on your mobile by
going to the Apple or Google Store and search for 'myEventflo'
iPhone App
Android App
www.myeventflo.com/2423